Kashima, A.; Kamiya, K.; Hamazaki, N.; Ueno, K.; Nozaki, K.; Ichikawa, T.; Yamashita, M.; Uchida, S.; Noda, T.; Hotta, K.;
et al. Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus. J. Clin. Med. 2022, 11, 5956.
https://doi.org/10.3390/jcm11195956
AMA Style
Kashima A, Kamiya K, Hamazaki N, Ueno K, Nozaki K, Ichikawa T, Yamashita M, Uchida S, Noda T, Hotta K,
et al. Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 2022; 11(19):5956.
https://doi.org/10.3390/jcm11195956
Chicago/Turabian Style
Kashima, Ayuko, Kentaro Kamiya, Nobuaki Hamazaki, Kensuke Ueno, Kohei Nozaki, Takafumi Ichikawa, Masashi Yamashita, Shota Uchida, Takumi Noda, Kazuki Hotta,
and et al. 2022. "Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus" Journal of Clinical Medicine 11, no. 19: 5956.
https://doi.org/10.3390/jcm11195956
APA Style
Kashima, A., Kamiya, K., Hamazaki, N., Ueno, K., Nozaki, K., Ichikawa, T., Yamashita, M., Uchida, S., Noda, T., Hotta, K., Maekawa, E., Yamaoka-Tojo, M., Matsunaga, A., & Ako, J.
(2022). Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine, 11(19), 5956.
https://doi.org/10.3390/jcm11195956
